1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2022 - East Asia

Chronic Disease Analysis & Statistics 2022 - East Asia

Customer Support

Talk to Grace

+1 718 618 4302

All regions

  • All
    • Asia
      • East Asia
1-3 of 3 reports

Pulmonary Embolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $ 2000
  • March 2022
  • 39 pages

Pulmonary Embolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism ...

  • World
  • South Korea
  • Cardiovascular Disease
  • Blood Disease
  • Investor presentation
  • Company

Company Analysis: AstraZeneca

  • $ 3000
  • January 2021
  • 87 pages

PharmaVitae explores AstraZeneca’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – AstraZeneca is poised for continued growth, driven by its oncology portfolio ...

  • World
  • China
  • Lung Cancer
  • Prescription Drug
  • Company research
  • Company

Grifols SA (GRF) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 75 pages

Summary Grifols SA (Grifols) is a pharmaceutical and chemical manufacturer that focuses on enhancing the health and well-being of people around the world.It conducts research, development, manufacturing ...

  • World
  • United States
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Company research
  • Company
  • Biologics Sales
  • Drug Approval


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on